August 23, 20112ThermoGenesis Sees Explosive Growth Opportunities in Stem Cells Mel Engle, CEO of ThermoGenesis [NASDAQ: KOOL] recently discussed with OneMedRadio, the company’s stem cell products and FDA approval that may have groundbreaking implications for the stem cell market.
